Havemeyer Place »

Intellia Therapeutics shares owned by Havemeyer Place

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Havemeyer Place from 13F filings

Historical chart of Havemeyer Place investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Havemeyer Place consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Havemeyer Place

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 109k 12.82

More positions owned by Havemeyer Place

Arm Holdings Sponsored Ads (ARM)
Cummins (CMI)
Autodesk (ADSK)
NVIDIA Corporation (NVDA)
Blackstone Group Inc Com Cl A (BX)
Johnson & Johnson (JNJ)
Dow (DOW)
Trane Technologies SHS (TT)
Advanced Micro Devices (AMD)
Capital One Financial (COF)
Veeva Sys Cl A Com (VEEV)
TTM Technologies (TTMI)
Te Connectivity Ord Shs (TEL)
Anthem (ELV)
Draftkings Com Cl A (DKNG)

View all positions for Havemeyer Place

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
D. E. Shaw & Co
Vanguard Capital Management
Two Sigma Investments
Regeneron Pharmaceuticals
UBS Group
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas

View all funds holding Intellia Therapeutics